Neurofibromatosis-1 in childhood

Advances in Dermatology

Volumn 20, Issue , 2004, Pages 75-115

  Listernick, Robert ^a,b   Charrow, Joel ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; GENOMIC DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; MACROGOL; MITOGEN ACTIVATED PROTEIN KINASE; NEUROFIBROMIN; PIRFENIDONE; POLYETHYLENE GLYCOL ALPHA2B INTERFERON; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAS PROTEIN; UNCLASSIFIED DRUG;

ACOUSTIC NEURINOMA; BONE DYSPLASIA; BRACE; CAFE AU LAIT SPOT; CANCER RISK; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE PREDISPOSITION; ECHOGRAPHY; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC COUNSELING; HAMARTOMA; HISTORY; HUMAN; INTELLIGENCE; IRIS; JUVENILE XANTHOGRANULOMA; LEARNING DISORDER; LENTIGO; LISCH NODULE; MACROCEPHALY; MENTAL DEFICIENCY; MENTAL PERFORMANCE; MORPHOLOGY; MOTOR COORDINATION; MYELOID LEUKEMIA; NEUROFIBROMA; NEUROFIBROMATOSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NERVE TUMOR; PATHOGENESIS; PHENOTYPE; PHEOCHROMOCYTOMA; RELATIVE; REVIEW; RHABDOMYOSARCOMA; SCOLIOSIS; SPHENOID; SPHENOID DYSPLASIA; SYMPTOM; VASCULAR DISEASE; VISUAL IMPAIRMENT; CHILD; GENETICS; PATHOLOGY; RADIOGRAPHY;

CHILD; HUMANS; NEUROFIBROMATOSIS 1;

EID: 16544377716     PISSN: 08820880     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (116)

1. Riccardi VM: Von Recklinghausen neurofibromatosis. N Engl J Med 305:1617-1627, 1981.
2. Akenside M: Observations on cancers. Med Trans Coll Physicians London 1:64-92, 1768.
3. Tilesius von Tilenau WG: Historia pathologica singularis cutis turpitudinus. Jo Godofredi Rheinhardi viri 50 Annorium. Leipzig, Germany, SL Crusins, 1793.
4. Virchow R: Über die reform der pathologischen und therapeutishcem Anshanngen durch die mikroskopischen Untersuchungen. Virchow Arch Pathol Anat Phys Klin Med 1:207, 1847.
5. Smith RW: A treatise on the pathology, diagnosis and treatment of neuromas, 1849, in An Atlas of Illustrations of Pathology, London, New Sydenham Society, 1898, p 38.
6. von Recklinghausen FD: Über die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen neuromen. Festschrift für Rudolph Virchow. Berlin, August Hirschwald, 1882.
7. Thomson A: On Neuroma and Neurofibromatosis. Edinburgh, Scotland, Turnbull & Spears, 1900.
8. Adrian C: Über Neurofibromatose und ihre Komplikationen. Beitr Klin Chir 31:1-98, 1901.
9. Preiser SA, Davenport CB: Multiple neurofibromatosis (von Recklinghausen's disease) and its inheritance with a description of a case. Am J Med Sci 156:507-540, 1918.
10. Crowe FW, Schull W: Diagnostic importance of café-au-lait spot in neurofibromatosis. Arch Intern Med 91:758-766, 1953.
11. Marie P, Bernard A: Neurofibromatose généralisée. Soc Med Hôp Paris 13:200, 1896.
12. Chauffard MA: Dermato-fibromatose pigmentaire (ou neuro-fibromatose généralisée). Soc Med Hôp Paris 13:777, 1896.
13. Eldridge R: Central neurofibromatosis with bilateral acoustic neuroma. Adv Neurol 29:57-65, 1981.
14. Riccardi VM: Neurofibromatosis: Clinical heterogeneity. Curr Probl Cancer 7:1-34, 1982.
15. National Institutes of Health: Neurofibromatosis. National Institutes of Health Consensus Development Conference. Bethesda, Md, The Institute, 6:1987.
16. Crowe FW, Schull WJ, Neel JV: A Clinical, Pathological and Genetic Study of Multiple Neurofibromatosis. Springfield, Ill, Charles C Thomas, 1956.
17. Whitehouse D: Diagnostic value of the café-au-lait spot in children. Arch Dis Child 41:316-319, 1966.
18. Crowe FW: Axillary freckling as a diagnostic aid in neurofibromatosis. Ann Intern Med 61:1142-1143, 1964.
19. Woodruff JM: Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am J Med Genet 89:23-30, 1999.
20. Friedman JM, Riccardi VM: Clinical and epidemiologic features, in Friedman JM, Gutmann DH, MacCollin M, et al (eds): Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. Baltimore, Md, The Johns Hopkins University Press, 1999, pp 29-86.
21. Dugoff L, Sujansky E: Neurofibromatosis type 1 and pregnancy. Am J Med Genet 66:7-10, 1996.
22. Xu G, O'Connell P, Viskochil D, et al: The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599-608, 1990.
23. Sawada S, Florell S, Purandare SM, et al: Identification of NF-1 mutations in both alleles of a dermal neurofibroma: Nat Genet 14:110-112, 1996.
24. Eisenbarth I, Beyer K, Krone W, et al: Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1. Am J Hum Genet 66:393-401, 2000.
25. Zhu Y, Ghosh P, Charnay P, et al: Neurofibromas in NF-1: Scwann cell origin and the role of tumour environment. Science 296:920-922, 2002.
26. Wolkenstein P, Freche B, Zeller J, et al: Usefulness of screening investigations in neurofibromatosis type 1. Arch Dermatol 132:1333-1336, 1996.
27. Tonsgard JH, Kwak SM, Short PM, et al: CT imaging in adults with neurofibromatosis-1: Frequent asymptomatic plexiform lesions. Neurology 50:1755-1760, 1998.
28. Vogel KS, Kleese LJ, Velasco-Miguel S, et al: Mouse tumor model for neurofibromatosis type 1. Science 286:2176-2179, 1999.
29. Cichowski K, Shih TS, Schmitt E, et al: Mouse models of tumor development in neurofibromatosis type 1. Science 286:2172-2176, 1999.
30. Huson SM, Harper PS, Compston DAS: Von Recklinghausen neurofibromatosis: A clinical and population study in southeast Wales. Brain 111:1355-1381, 1988.
31. Lewis RA, Gerson LP, Axelson KA, et al: Von Reclinghausen neurofibromatosis: Incidence of optic gliomata. Ophthalmology 91:929-935, 1984.
32. Listernick R, Charrow J, Greenwald MJ, et al: Optic gliomas in children with neurofibromatosis type 1. J Pediatr 114:788-792, 1989.
33. Listernick R, Charrow J, Greenwald M, et al: Natural history of optic pathway tumors in children with neurofibromatosis type I: A longitudinal study. J Pediatr 125:63-66, 1994.
34. Habiby R, Silverman B, Listernick R, et al: Precocious puberty in children with neurofibromatosis type 1. J Pediatr 126:364-367, 1995.
35. Parsa CF, Hoyt CS, Lesser RL, et al: Spontaneous regression of optic gliomas: Thirteen cases documented by serial neuroimaging. Arch Ophthalmol 119:516-529, 2001.
36. Listernick R, Louis DN, Packer RJ, et al: Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 41:143-149, 1997.
37. Listernick R, Charrow J, Tomita T, et al: Carboplatin therapy for optic pathway tumors in children with neurofibromatosis type 1. J Neurooncol 45:185-190, 1999.
38. Packer RJ, Ater J, Allen J, et al: Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86:747-754, 1997.
39. Listernick R, Charrow J, Greenwald M: Emergence of optic pathway gliomas in children with neurofibromatosis type 1 after normal neuroimaging results. J Pediatr 121:584-587, 1992.
40. Obringer AC, Meadows AT, Zackai EH: The diagnosis of neurofibromatosis-1 in the child under the age of 6 years. Am J Dis Child 143:717-719, 1989.
41. Lewis RA, Riccardi VM: Von Recklinghausen neurofibromatosis: Incidence of iris hamartomata. Ophthalmology 88:348-354, 1981.
42. Listernick R, Mancini AJ, Charrow J: Segmental neurofibromatosis in childhood. Am J Med Genet 121:132-135, 2003.
43. Ruggieri M, Huson SM: The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 56:1433-1443, 2001.
44. Kristiansen LP, Steen H, Terjesen T: Residual challenges after healing of congenital pseudarthrosis in the tibia. Clin Orthop 414:228-237, 2003.
45. Paley D, Catagni M, Argnani F, et al: Treatment of congenital pseudoarthrosis of the tibia using the Ilizarov technique. Clin Orthop 280:81-93, 1992.
46. Vitale MG, Guha A, Skaggs DL: Orthopaedic manifestations of neurofibromatosis in children: An update. Clin Orthop 401:107-118, 2002.
47. Carey JC, Laub JM, Hall BD: Penetrance and variability in neurofibromatosis: A genetic study of 60 families. Birth Defects 15:271-281, 1979.
48. Riccardi VM, Eichner JE: Neurofibromatosis. Phenotype, Natural History and Pathogenesis. Baltimore, Md, Johns Hopkins University Press, 1986.
49. Rubenstein A, Wallerstein R, Aron A, et al: Lack of correlation of megalencephaly with learning disability in disseminated neurofibromatosis. Am J Hum Genet 37:A74, 1985.
50. DiPaolo DP, Zimmerman RA, Rorke LB, et al: Neurofibromatosis type 1: Pathologic substrate of high-signal-intensity foci in the brain. Radiology 195:721-724, 1995.
51. Sorensen SA, Mulvihill JJ, Nielsen A: Long-term follow-up of von Recklinghausen neurofibromatosis survival and malignant neoplasms. N Engl J Med 314:1010-1015, 1986.
52. Matsui I, Tanimura M, Kobayashi N, et al: Neurofibromatosis type 1 and childhood cancer. Cancer 72:2746-2754, 1993.
53. Evans DGR, Baser ME, McGaughran J, et al: Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39:311-314, 2002.
54. 18fluorodeoxyglucose positron emission tomography in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry 68:353-357, 2000.
55. Stiller CA, Chessells JM, Fitchett M: Neurofibromatosis and childhood leukaemia/lymphoma: A population-based UKCCSG study. Br J Cancer 70:969-972, 1994.
56. Bader JL, Miller RW: Neurofibromatosis and childhood leukemia. J Pediatr 92:925-929, 1978.
57. Side L, Taylor B, Cayouette M, et al: Homozygous inactivation of the NF-1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med 336:1713-1720, 1997.
58. Cooper PH, Frierson HF, Kayne AL, et al: Association of juvenile xanthogranuloma with juvenile myeloid leukemia. Arch Dermatol 120:371-375, 1984.
59. Zvulunov A, Barak Y, Metzker A: Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia: World statistical analysis. Arch Dermatol 131:904-908, 1995.
60. McKeen EA, Bodurtha J, Meadows AT, et al: Rhabdomyosarcoma complicating multiple neurofibromatosis. J Pediatr 93:992-993, 1978.
61. Walther MM, Herring J, Enquist E, et al: Von Recklinghausen's disease and pheochromocytomas. J Urol 162:1582-1586, 1999.
62. Xu W, Mulligan LM, Ponder MA, et al: Loss of NF-1 alleles in phaeochromocytomas from patients with type 1 neurofibromatosis. Genes Chromosomes Cancer 4:337-342, 1992.
63. Gutmann DH, Cole JL, Stone WJ, et al: Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type 1. Genes Chromosomes Cancer 10:55-58, 1993.
64. Hamilton SJ, Friedman JM: Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet 58:341-344, 2000.
65. Salyer WR, Salyer DC: The vascular lesions of neurofibromatosis. Angiology 25:510-519, 1974.
66. Kurien A, John PR, Milford DV: Hypertension secondary to progressive vascular neurofibromatosis. Arch Dis Child 76:454-455, 1997.
67. Fossali E, Signorini E, Intermite RC, et al: Renovascular disease and hypertension in children with neurofibromatosis. Pediatr Nephrol 14:806-810, 2000.
68. Eliason MJ: Neuropsychological patterns: Neurofibromatosis compared to developmental learning disorders. Neurofibromatosis 1:17-25, 1988.
69. Ferner RE, Hughes RAC, Wenman J: Intellectual impairment in neurofibromatosis 1. J Neurol Sci 138:125-133, 1996.
70. Legius EM, Descheemaeker MJ, Spaepen A, et al: Neurofibromatosis type 1 in childhood: A study of the neuropsychological profile in 45 children. Genet Couns 5:51-60, 1994.
71. Moore BD, Ater JL, Needle MN, et al: Neuropsychological profile of children with neurofibromatosis, brain tumor or both. J Child Neurol 9:368-377, 1994.
72. Moore BD, Slopis JM, Schomer D, et al: Neuropsychological significance of areas of high signal intensity on brain magnetic resonance imaging scans of children with neurofibromatosis. Neurology 46:1660-1668, 1996.
73. North K, Joy P, Yuille D, et al: Cognitive function and academic performance in children with neurofibromatosis type 1. Dev Med Child Neurol 37:427-436, 1995.
74. North K, Joy P, Yuille D, et al: Specific learning disability in children with neurofibromatosis type 1: Significance of MRI abnormalities. Neurology 44:878-883, 1994.
75. North KN, Riccardi V, Samango-Sprouse C, et al: Cognitive function and academic performance in neurofibromatosis. 1: Consensus statement from the NF1 Cognitive Disorders Task Force. Neurology 48:1121-1127, 1997.
76. Wadsby M, Lindenhammer H, Eeg-Olofsson O: Neurofibromatosis in childhood: Neuropsychological aspects. Neurofibromatosis 2:251-260, 1989.
77. Eldridge R, Denckla MB, Bien E, et al: Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls. Am J Dis Child 143:833-837, 1989.
78. Hofman KJ, Harris EL, Bryan RN, et al: Neurofibromatosis type 1: The cognitive phenotype. J Pediatr 124:S1-S8, 1994.
79. Eliason MJ: Neurofibromatosis: Implications for learning and behavior. J Dev Behav Pediatr 7:175-179, 1986.
80. Ferner RE, Hughes RAC: Intellectual problems in neurofibromatosis 1, in SM Huson, Hughes RAC (eds): The Neurofibromatoses: A Pathogenetic and Clinical Overview. London, Chapman and Hall Medical, 1994.
81. Moore BD: NF1, cognition, and MRI. Neurology 45:1029, 1995.
82. Dunn DW, Roos KL: Magnetic resonance imaging evaluation of learning difficulties and incoordination in neurofibromatosis. Neurofibromatosis 2:1-5, 1989.
83. Mautner V-F, Schneider E, Fabra M, et al: Klinishe bedeutung signalintenser herde in der zerebralen magnetresonanztomographie bei neurofibromatose. Fortschr Neurol Psychiatr 59:25-30, 1991.
84. Duffner PK, Cohen ME, Seidel FG, et al: The significance of MRI abnormalities in children with neurofibromatosis. Neurology 39:373-378, 1989.
85. Ferner RE, Chaudhuri R, Bingham J, et al: MRI in neurofibromatosis 1: The nature and evolution of increased intensity T2-weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 56:492-495, 1993.
86. Moore BD, Slopis J: Neuropsychological significance of areas of high signal intensity (heterotopias) seen on brain MRI in children with NF, type 1. J Int Neuropsychol Soc 1:158, 1995.
87. Joy P, Roberts C, North K, et al: Neuropsychological function and MRI abnormalities in neurofibromatosis type 1. Dev Med Child Neurol 37:906-914, 1995.
88. Miller M, Hall JG: Possible maternal effect of severity of neurofibromatosis. Lancet 2:1071-1073, 1978.
89. Kayes LM, Burke W, Riccardi VM, et al: Deletions spanning the neurofibromatosis I gene: Identification and phenotype of five patients. Am J Hum Genet 54:424-436, 1994.
90. Clementi M, Barbujani G, Turolla L, et al: Neurofibromatosis-1: A maximum likelihood estimation of mutation rate. Hum Genet 84:116-118, 1990.
91. Samuelsson B, Akesson HO: Relative fertility and mutation rate in neurofibromatosis. Hereditas 108:169-171, 1988.
92. Jadayel D, Fain P, Upadhyaya M, et al: Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature 343:558-559, 1990.
93. Dasgupta B, Gutmann DH: Closing the GAP between mice and men. Curr Opin Genet Dev 13:20-27, 2003.
94. Costa RM, Silva AJ: Mouse models of neurofibromatosis type 1: Bridging the GAP. Trends Mol Med 9:19-23, 2003.
95. Feng-Chun Y, Ingram DA, Chen S, et al: Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells. J Clin Invest 112:1851-1861, 2003.
96. Bajenaru ML, Hernandez MR, Perry A, et al: Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res 63:8573-8577, 2003.
97. Cawthon RM, Weiss R, Xu G, et al: A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62:193-201, 1990.
98. Wallace MR, Marchuk DA, Andersen LB, et al: Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science 249:181-186, 1990.
99. Viskochil D, Buchberg AM, Xu G, et al: Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62:187-192, 1990.
100. Marchuk DA, Saulino AM, Tavakkol R, et al: cDNA cloning of the type 1 neurofibromatosis gene: Complete sequence of the NF1 gene product. Genomics 11:931-940, 1991.
101. Heim RA, Kam-Morgan LN, Binnie CG, et al: Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet 4:975-981, 1995.
102. Park VM, Pivnick EK: Neurofibromatosis type 1 (NF1): A protein truncation assay yielding identification of mutations in 73% of patients. J Med Genet 35:813-820, 1998.
103. Messiaen LM, Callens T, Mortier G, et al: Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 15:541-555, 2000.
104. Ruggieri M, Huson SM: The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 56:1433-1443, 2001.
105. Tinschert S, Naumann I, Stegmann E, et al: Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet 8:455-459, 2000.
106. Listernick R, Mancini A, Charrow J: Segmental neurofibromatosis in childhood. Am J Med Genet 121A:132-135, 2003.
107. Perry A, Roth KA, Banerjee R, et al: NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF-1) associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. Am J Pathol 159:57-61, 2001.
108. Vitale MG, Guha A, Skaggs DL: Orthopaedic manifestations of neurofibromatosis: An update. Clin Orthop Rel Res 401:107-118, 2002.
109. Lazaro C, Ravella A, Gaona A, et al: Neurofibromatosis type 1 due to germ line mosaicism in a clinically normal father. N Engl J Med 331:1403-1407, 1994.
110. Boltshauser E, Stocker H, Machler M: Neurofibromatosis type 1 in a child of a parent with segmental neurofibromatosis (NF-5). Neurofibromatosis 2:244-245, 1989.
111. Rubenstein A, Bader JL, Aron AA, et al: Familial transmission of segmental neurofibromatosis. Neurology 33:76S, 1983.
112. Huson SM, Ruggieri M: The neurofibromatoses, in Harper J, Oranje JM, Rose M (eds): Textbook of Pediatric Dermatology, vol 2. Oxford, Blackwell Science, 2000, pp 1204-1224.
113. Arnsmeier SL, Riccardi VM, Paller AS: Familial multiple cafe au lait spots. Arch Dermatol 130:1425-1426, 1994.
114. Abeliovich D, Gelman-Kohan Z, Silverstein S, et al: Familial cafe au lait spots: A variant of neurofibromatosis type 1. J Med Genet 32:985-986, 1995.
115. Brunner HG, Hulsebos T, Steijlen PM, et al: Exclusion of the neurofibromatosis 1 locus in a family with inherited cafe-au-lait spots. Am J Med Genet 46:472-474, 1993.
116. Charrow J, Listernick R, Ward K: Autosomal dominant multiple cafe-au-lait spots and neurofibromatosis-1: evidence of non-linkage. Am J Med Genet 45:606-608, 1993.